In one of his latest investor conference appearance, Exact Sciences CEO Kevin Conroy delivered the company's presentation at the 2014 Baird Healthcare Conference September 4, 2014.

Conroy discussed Exact Sciences' plans following FDA's approval of Cologuard®, Exact Sciences' first-of-its-kind, noninvasive colon cancer screening test that patients can use at home.

You can view Conroy's slides below, and listen to his presentation on the Baird website.